SCHEMBL5147388

SCHEMBL5147388

CC1(C)NC(=O)N(CCNc2nccc(-c3scc(Br)c3-c3ccccc3)n2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
EIF2AK2 P19525 2/20 0.37
CDK2 P24941 1/20 0.36
CLK1 P49759 1/20 0.36
LMNA P02545 3/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RAF1 P04049 5/20 0.34
BRAF P15056 5/20 0.34
MAPK13 O15264 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
MAPK14 Q16539 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 2/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147284 0.88 ALDH1A1 (0.36) ALDH1A1EIF2AK2CDK2CLK1LMNA
SCHEMBL5148871 0.87 ALDH1A1 (0.40) ALDH1A1CDK2CLK1HTTSMN1; SMN2
SCHEMBL2984010 0.86 EIF2AK2 (0.39) EIF2AK2CDK2CLK1RAF1BRAF
SCHEMBL5147410 0.78 ALDH1A1 (0.41) ALDH1A1CDK2CLK1HTTRAF1
SCHEMBL5212419 0.77 RAF1 (0.32) EIF2AK2CDK2CLK1RAF1BRAF
SCHEMBL5147395 0.77 CDK2 (0.38) ALDH1A1CDK2CLK1LMNATSHR
SCHEMBL5147359 0.77 ALDH1A1 (0.45) ALDH1A1CDK2CLK1LMNARAF1
SCHEMBL3167891 0.77 EIF2AK2 (0.35) EIF2AK2CDK2CLK1RAF1BRAF
SCHEMBL2978487 0.75 EIF2AK2 (0.37) ALDH1A1EIF2AK2CDK2CLK1MAPK1
SCHEMBL5182109 0.75 ALDH1A1 (0.42) ALDH1A1CDK2CLK1LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed